SINGAPORE, PARIS and PHILADELPHIA, April 28, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotec...
SINGAPORE, July 7, 2025 /PRNewswire/ -- Nuevocor
* LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affe...
– Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participat...
SINGAPORE and PHILADELPHIA, Jan. 24, 2025 /PRNewswire/ -- Nuevocor
SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechn...
SINGAPORE, Nov. 7, 2023 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnologycompany focused...
SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- Nuevocor
SINGAPORE, Oct. 28, 2022 /PRNewswire/ -- Nuevocor, a pre-clinical stage cardiac gene therapy compan...
SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing...